• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.

作者信息

García-González Martín J, Domínguez-Rodríguez Alberto, Ferrer-Hita Julio J

机构信息

Coronary Care Unit, Department of Cardiology, Hospital Universitario de Canarias, Tenerife, Spain.

出版信息

J Clin Pharmacol. 2005 Jun;45(6):704-8. doi: 10.1177/0091270004273849.

DOI:10.1177/0091270004273849
PMID:15901754
Abstract
摘要

相似文献

1
Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.新型钙增敏剂左西孟旦在治疗ST段抬高型心肌梗死患者心肌顿抑所致心源性休克中的应用：病例系列
J Clin Pharmacol. 2005 Jun;45(6):704-8. doi: 10.1177/0091270004273849.
2
Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.左西孟旦作为ST段抬高型心肌梗死后严重心源性休克的挽救治疗。
Acute Card Care. 2008;10(3):185-90. doi: 10.1080/17482940801935774.
3
Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty.左西孟旦与多巴酚丁胺对直接冠状动脉血管成形术后心源性休克患者长期生存的影响。
Int J Cardiol. 2008 Jul 4;127(2):284-7. doi: 10.1016/j.ijcard.2007.04.143. Epub 2007 Jul 23.
4
Early 'in-lab' use of levosimendan in patients with cardiogenic shock unsuitable for intra-aortic balloon pump counterpulsation.左西孟旦在不适合主动脉内球囊反搏的心源性休克患者中的早期“实验室”应用。
Ther Adv Cardiovasc Dis. 2014 Feb;8(1):28-31. doi: 10.1177/1753944713515310.
5
Levosimendan: a promising treatment for myocardial stunning?
Anaesthesia. 2006 Jan;61(1):61-3. doi: 10.1111/j.1365-2044.2005.04431.x.
6
Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.直接经皮冠状动脉介入治疗后的心源性休克：左西孟旦与多巴酚丁胺对血流动力学影响的比较
Eur J Heart Fail. 2006 Nov;8(7):723-8. doi: 10.1016/j.ejheart.2006.01.007. Epub 2006 Feb 21.
7
[Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction].[左西孟旦成功用于一名并发急性心肌梗死的心源性休克患者]
Tunis Med. 2005 Oct;83(10):635-7.
8
Efficacy of levosimendan in Takotsubo-related cardiogenic shock.左西孟旦在应激性心肌病相关心源性休克中的疗效。
Acta Anaesthesiol Scand. 2010 Jan;54(1):119-20. doi: 10.1111/j.1399-6576.2009.02105.x.
9
Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.左西孟旦对心肌顿抑所致心室功能障碍性心力衰竭的药物治疗：潜在作用
Am J Cardiovasc Drugs. 2006;6(2):69-75. doi: 10.2165/00129784-200606020-00001.
10
The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.钙敏化剂左西孟旦可改善急性心肌缺血经皮腔内冠状动脉成形术后顿抑心肌的功能。
J Am Coll Cardiol. 2004 Jun 16;43(12):2177-82. doi: 10.1016/j.jacc.2004.02.052.

引用本文的文献

1
A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock.心源性休克管理中血管活性药物的临床最新进展
Clin Med Insights Cardiol. 2022 Feb 7;16:11795468221075064. doi: 10.1177/11795468221075064. eCollection 2022.
2
Levosimendan in critical illness: a literature review.左西孟旦在危重症中的应用：文献综述
J Clin Med Res. 2014 Apr;6(2):75-85. doi: 10.14740/jocmr1702w. Epub 2014 Feb 6.